Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy-Reference-Cited by-同舟云学术

Effect of Cytomegalovirus Infection on Survival of Older Kidney Transplant Patients (D+/R+): Impact of Valganciclovir Prophylaxis Versus Preemptive Therapy

Published:2016-11 Issue:9 Volume:48 Page:2931-2937
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Luna E.,Caravaca F.,Ferreira F.,Fernandez N.,Martín P.,Vargas M.L.,Saenz de Santamaría J.,Garcia Pino G.,Azevedo L.,Muñoz Sanz A.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference35 articles.

1. Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival;Dzabic;Clin Infect Dis,2011

2. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation;Rubin;JAMA,1989

3. Cytomegalovirus infection in renal transplant recipients;Carstens;Transpl Infect Dis,2006

4. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report;Opelz;Am J Transplant,2004

5. Revisiting the effects of CMV on long-term transplant outcome;Baron;Curr Opin Organ Transplant,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation;Transplantation Direct;2024-07-26

2. Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study;Clinical and Experimental Nephrology;2024-04-13

3. Cytomegalovirus infection in kidney transplant patients: Prevalence, risk factors, and impact on outcome – A local multicentre experience;Transplant Immunology;2021-12

4. A Comprehensive Review of Infections in Older Kidney Transplant Recipients;Current Transplantation Reports;2021-02-22

5. Among CMV‐positive renal transplant patients receiving non‐T‐cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients;Transplant Infectious Disease;2021-02-18